Skip to content

CTY CITY THERAPEUTICS INC

Follow

Common Stock, par value $0.0001 per share (common), issuer CIK 2143850

No 13F filer reports this security in the loaded quarters.

13D and 13G filers

Each filer's latest stake. The shares are the aggregate the reporting persons state, which can include entities that file no 13F.

Insider trades

No Form 4 transaction on this security in the data.

Events

  • FMR LLC and 1 other reporting person reported 7,025,543 CTY shares, 14% of the class, as of 2026-10-30, in a 13G filed 2026-11-06. 0000315066-26-002961

    Accepted , ingested
  • ARCH Venture Fund XII, L.P. and 6 other reporting persons reported 13,692,507 CTY shares, 25.6% of the class, as of 2026-10-19, in a 13D filed 2026-10-26. 0001193125-26-432028

    Accepted , ingested
  • VIKING GLOBAL INVESTORS LP and 9 other reporting persons reported 3,727,005 CTY shares, 7% of the class, as of 2026-10-19, in a 13G filed 2026-10-26. 0000905148-26-004557

    Accepted , ingested
  • Invus Global Management, LLC and 7 other reporting persons reported 4,342,866 CTY shares, 8.1% of the class, as of 2026-10-16, in a 13G filed 2026-10-22. 0002005369-26-000056

    Accepted , ingested